Endocyte Inc
(ECYT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Sales | 34,682 | 191 | 0 | 3,000 | 500 |
| Gross Profit | 34,682 | 191 | N/A | 3,000 | 500 |
| Operating Expenses | 50,725 | 38,828 | 20,600 | 18,738 | 18,109 |
| Operating Income | -16,043 | -38,637 | -20,600 | -15,738 | -17,609 |
| Interest Expense | 629 | 1,988 | 1,065 | 1,436 | 1,579 |
| Other Income | -620 | 93 | 1,572 | 168 | 695 |
| Pre-tax Income | -17,292 | -40,532 | -20,093 | -17,006 | -18,493 |
| Net Income Continuous | -17,292 | -40,532 | -20,093 | -17,006 | -18,493 |
| Net Income | $-17,292 | $-40,532 | $-20,093 | $-17,006 | $-18,493 |
| EPS Basic Total Ops | -0.48 | -1.40 | -21.77 | -18.67 | -20.54 |
| EPS Basic Continuous Ops | -0.48 | -1.40 | -21.77 | -18.67 | -20.04 |
| EPS Diluted Total Ops | -0.48 | -1.40 | -21.77 | -18.67 | -20.54 |
| EPS Diluted Continuous Ops | -0.48 | -1.40 | -21.77 | -18.67 | -20.04 |
| EPS Diluted Before Non-Recurring Items | -0.45 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-14,723 | $-38,031 | $-20,343 | $-15,523 | $-17,289 |